The prominent players in the dental implants and prosthetics market are Institut Straumann AG (Switzerland), Envista Holdings Corporation (Danaher Corporation) (US), DENTSPLY Sirona, Inc. (US), 3M Company (US), Zimmer Biomet
The Nonalcoholic Steatohepatitis market report provides current treatment practices, emerging drugs, Nonalcoholic Steatohepatitis market share of the individual therapies, current and forecasted Nonalcoholic Steatohepatitis market Size from 2019 to 2032
The Fuchs Endothelial Corneal Dystrophy market report provides current treatment practices, emerging drugs, Fuchs Endothelial Corneal Dystrophy market share of the individual therapies, current and forecasted Fuchs Endothelial Corneal Dystrophy
Browse 87 market data Tables and 33 Figures spread through 128 Pages and in-depth TOC on “Anti-Slip Additives Market” Anti-Slip Additives Market by Type (Aluminium Oxide, Silica, Others (Polymer Grits/Beads,
DelveInsight’s, “Urothelial Carcinoma Pipeline Insight, 2022,” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in the Urothelial Carcinoma pipeline landscape. It covers the pipeline drug profiles, including
The Spinal Muscular Atrophy Market report provides current treatment practices, emerging drugs, Spinal Muscular Atrophy market share of the individual therapies, current and forecasted Spinal Muscular Atrophy market Size from
The Methicillin-resistant Staphylococcus aureus market report provides current treatment practices, emerging drugs, Methicillin-resistant Staphylococcus aureus market share of the individual therapies, current and forecasted Methicillin-resistant Staphylococcus aureus market Size from
Side View Camera System Market to surpass USD 7,866.6 million by 2031 from USD 4.6 million in 2021 at a CAGR of 110.6% in the coming years, i.e., 2021-31. Side
Smart Pulse Oximeters Market to surpass USD 2.2 billion by 2031 from USD 1.43 billion in 2021 at a CAGR of 7.7% in the coming years, i.e., 2021-31. Smart Pulse
Stem cell therapy Market to surpass USD 27.94 billion by 2031 from USD 11.43 billion in 2021 at a CAGR of 13.4% in the coming years, i.e., 2021-31. Stem cell
